Literature DB >> 22891173

Disseminated sarcoidosis resulting in portal hypertension and gastrointestinal bleeding: a rare presentation.

Chinedu Ivonye1, Balsam Elhammali, Marhaleen Henriques-Forsythe, Raquel Bennett-Gittens, Adesoji Oderinde.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22891173      PMCID： PMC3414469          DOI： 10.1155/2012/326357

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN： 0835-7900            Impact factor:   3.522


× No keyword cloud information.
  5 in total

1.  Sarcoidosis producing portal hypertension; treatment by splenectomy and splenorenal shunt.

Authors:  R A MINO; A I MURPHY; R G LIVINGSTONE
Journal:  Ann Surg       Date:  1949-11       Impact factor: 12.969

Review 2.  Sarcoidosis of the liver and bile ducts.

Authors:  K G Ishak
Journal:  Mayo Clin Proc       Date:  1998-05       Impact factor: 7.616

3.  Sarcoidosis and chronic hepatic disease: a clinical and pathologic study of 20 patients.

Authors:  W C Maddrey; C J Johns; J K Boitnott; F L Iber
Journal:  Medicine (Baltimore)       Date:  1970-09       Impact factor: 1.889

Review 4.  Hepatic sarcoidosis.

Authors:  Alexandros Karagiannidis; Maria Karavalaki; Anastasios Koulaouzidis
Journal:  Ann Hepatol       Date:  2006 Oct-Dec       Impact factor: 2.400

Review 5.  Clinical manifestations of sarcoid liver disease.

Authors:  Miry Blich; Yeouda Edoute
Journal:  J Gastroenterol Hepatol       Date:  2004-07       Impact factor: 4.029
  5 in total
  2 in total

1.  Successful treatment of refractory midgut bleeding with ocreotide and corticosteroids in a dialysis patient with suspected sarcoidosis.

Authors:  Nestor Velasco; Toufeeq Imtiaz; Amir Ali Shah; Anastasios Koulaouzidis
Journal:  BMJ Case Rep       Date:  2016-07-14

2.  Hepatic and Gastric Involvement in a Case of Systemic Sarcoidosis Presenting with Rupture of Esophageal Varices.

Authors:  Hiroaki Saito; Masayasu Ohmori; Masaya Iwamuro; Takehiro Tanaka; Nozomu Wada; Tetsuya Yasunaka; Akinobu Takaki; Hiroyuki Okada
Journal:  Intern Med       Date:  2017-09-06       Impact factor: 1.271
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.